-
Promoting NICHD Areas of Research for HIV/AIDS in Maternal and Child Health (R01)
(PA-17-262)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on .
-
Innovation for HIV Vaccine Discovery (R01)
(PAR-17-263)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): August 1, 2017; August 1, 2018; August 1, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
-
Innovative Mental Health Services Research Not Involving Clinical Trials (R01)
(PAR-17-264)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76)
(RFA-AG-18-006)
National Institute on Aging
Application Receipt Date(s): October 19, 2017), by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Coordinating Center for Claude D. Pepper Older Americans Independence Centers (U24)
(RFA-AG-18-008)
National Institute on Aging
Application Receipt Date(s): October 19, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Novel Cell Non-autonomous Mechanisms of Aging (R01)
(RFA-AG-18-009)
National Institute on Aging
Application Receipt Date(s): October 3, 2017 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Nasal Delivery of CNS Therapeutics (R43/R44)
(RFA-DA-18-006)
National Institute on Drug Abuse
Application Receipt Date(s): August 23, 2017, by 5:00 PM local time of applicant organization.
-
Nasal Delivery of CNS Therapeutics (R41/R42)
(RFA-DA-18-007)
National Institute on Drug Abuse
Application Receipt Date(s): August 23, 2017, by 5:00 PM local time of applicant organization.
-
Limited Competition: Follow-up on Subjects and Immunological Assessments in The Environmental Determinants of Diabetes In The Young Study (TEDDY) (UC4)
(RFA-DK-17-508)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): July 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R43/R44)
(RFA-HL-17-023)
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
National Center for Advancing Translational Sciences
Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization.
All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R41/R42)
(RFA-HL-17-024)
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
National Center for Advancing Translational Sciences
Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization.
All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U54)
(RFA-HL-17-025)
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
National Center for Advancing Translational Sciences
Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM1)
(RFA-HL-17-026)
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
National Center for Advancing Translational Sciences
Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UC4)
(RFA-HL-17-027)
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
National Center for Advancing Translational Sciences
Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U24)
(RFA-HL-17-028)
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
National Center for Advancing Translational Sciences
Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R01)
(RFA-HL-17-029)
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
National Center for Advancing Translational Sciences
Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R24)
(RFA-HL-17-030)
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
National Center for Advancing Translational Sciences
Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM2)
(RFA-HL-17-031)
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
National Center for Advancing Translational Sciences
Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P50)
(RFA-HL-17-032)
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
National Center for Advancing Translational Sciences
Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P41)
(RFA-HL-17-033)
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
National Center for Advancing Translational Sciences
Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U01)
(RFA-HL-17-034)
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Institute of Biomedical Imaging and Bioengineering
National Center for Advancing Translational Sciences
Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Translational Outcomes Project in Neurotrauma (TOP-NT) (UG3/UH3)
(RFA-NS-17-023)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): August 21, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late Applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.